Skip to content
Open access

MHR and AIP as Differential Predictors of 1-Year Major Adverse Cardiovascular and Cerebrovascular Events After Acute Ischemic Stroke: A Combined Model Study

Oct 2026 · Clinical Interventions in Aging · Vol 21 · 0 citations · 39 references
Medicine

Abstract

Objective To evaluate the predictive value of monocyte-to-high-density lipoprotein cholesterol ratio (MHR), plasma atherogenic index (AIP), and baseline National Institutes of Health Stroke Scale (NIHSS) score for 1-year major adverse cardiovascular and cerebrovascular events (MACCE) after acute ischemic stroke, and to explore potential differences in their predictive patterns across endpoint subtypes. Methods This retrospective study enrolled 429 elderly patients (≥65 years) with acute ischemic stroke admitted to Lu’an People’s Hospital (Anhui, China) between January 2020 and September 2023. Clinical and laboratory data were collected; MHR and AIP were Z-standardized. Patients were followed for 1 year for MACCE (stroke recurrence, all-cause mortality, non-fatal myocardial infarction/angina). Independent predictors were identified using multivariable logistic regression (Enter method: full model, then parsimonious model). Receiver operating characteristic (ROC) curves and DeLong tests compared individual and combined (MHR+AIP+baseline NIHSS) models. Endpoint-specific analyses were exploratory. Bootstrap resampling was performed for internal validation. Results MACCE occurred in 115 patients (26.8%), comprising 58 stroke recurrences, 41 deaths, and 17 coronary events. MHR (per 1-SD increase: OR=2.765, 95% CI: 2.062–3.707, P<0.001), AIP (per 1-SD increase: OR=1.682, 95% CI: 1.289–2.193, P<0.001), and Baseline NIHSS score (OR=1.170, 95% CI: 1.108–1.235, P<0.001) were independent predictors of MACCE. In exploratory endpoint-specific analyses, MHR was associated with all three subtypes, while AIP was associated with stroke recurrence and coronary events but not all-cause mortality. However, formal interaction tests were underpowered. AUCs were 0.731 (MHR), 0.628 (AIP), 0.646 (NIHSS), and 0.810 (combined); the combined model outperformed all individual markers (all P<0.05 by DeLong test). Conclusion MHR and AIP independently predict 1-year MACCE in elderly stroke patients. The observed differences in their associations across endpoint subtypes are exploratory and hypothesis-generating; formal interaction tests or adequately powered prospective studies are required. The combined model may improve risk stratification, but requires prospective validation.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.